Private Label Tranexamic & Kojic Acid Body Lotion Low MOQ

What percentage of tranexamic acid and kojic acid should be in a body lotion?

By Blake Mereby · Last reviewed October 4, 2026

The working concentration ranges for tranexamic acid and kojic acid in a body lotion are driven by a combination of efficacy evidence, stability constraints, and regulatory limits, and they differ meaningfully between the two actives.

Transexamic acid (TXA) is used in cosmetic formulations at concentrations ranging from 2% to 5%. Most published in-vitro and clinical studies supporting TXA's brightening mechanism used concentrations in the 2% to 3% range for topical applications. Some manufacturers formulate at up to 5% for a more aggressive efficacy positioning, though there is no regulatory cap on TXA concentration in cosmetics in major markets as of current guidance. Below 2%, consumer-perceptible efficacy is questionable; above 5%, the incremental benefit is unclear and the cost per unit increases significantly because TXA is a pharmaceutical-grade raw material.

Kojic acid presents more constraints. The SCCS-informed guideline for leave-on products in the EU is ≤1%. For the US market, there is no regulatory cap, and concentrations of 1% to 2% are common in commercial products. Most formulators working on a globally exportable product set kojic acid at exactly 1% to comply with the most restrictive applicable market (EU) while still delivering efficacy. At concentrations above 2%, there is a meaningful risk of irritation and sensitization, especially on abraded or sun-damaged skin — the kind of skin that brightening body lotion customers typically have.

Stability is the second reason to keep kojic acid concentration conservative. Higher concentrations of kojic acid in an aqueous emulsion increase the risk of visible discoloration (the product turning orange, yellow, or brown) if the antioxidant and chelation system isn't perfectly calibrated. A cosmetic chemist will typically add sodium metabisulfite or ascorbic acid as an antioxidant and EDTA as a chelating agent to protect kojic acid from oxidative degradation. The finished product pH should be maintained between 4.5 and 5.5 — above pH 6, kojic acid stability drops sharply.

Niacinamide is commonly added as a third brightening agent at 2% to 5%, which gives the formula a triple-mechanism story without adding regulatory complexity. However, formulators must test the TXA + kojic acid + niacinamide combination for compatibility — niacinamide can form a niacin complex with certain ingredients that causes facial flushing, though this is less of a concern in body lotion rinse-off or leave-on contexts at these concentrations.

The practical recommendation for a first-time formulation: start at TXA 2%, kojic acid 1%, niacinamide 3%, and run a full stability and PET study before committing to a commercial batch. Adjust actives upward in future iterations based on stability results and consumer feedback.

Ingredients in this answer: Tranexamic Acid · Kojic Acid · Ascorbic Acid · Niacinamide

Read the full guide on Private Label Tranexamic & Kojic Acid Body Lotion Low MOQ →

More about Private Label Tranexamic & Kojic Acid Body Lotion Low MOQ

Tell us about your product

Tell us what you're making. Get an AI-drafted starting formula free, then have a vetted cosmetic chemist check it.

Free to start · no credit card · continue in your browser or the iPhone app.

Have a product idea?

Connect with vetted cosmetic chemists and custom labs on AJ Cosmo Labs.

Get on the App Store Open the web app